SEARCH:

Health News Archives

Blood Disorders

Promacta Approved for Rare Blood Disorder
Affects about 60,000 people in United States

’Fresh’ Transfusions Improve Odds for Cancer Patients After Surgery
But only if the blood was less than nine days old, study found

China Documents First Case of Tick-Borne Disease Spread
Human-to-human transfer caused by contact with blood, respiratory secretion

Cancer Drug Ups Risk of Clots in Veins
Those on Avastin faced 33% increased risk of dangerous side effect

Blood Sugar Control Helps Diabetics Preserve Sight
Close monitoring means type 1 patients can avoid retinopathy, study suggests

Flu Shots Lower Risk of Blood Clots
Study found getting one reduced chances by 26%

Statins Lower Blood Marker for Prostate Cancer
But it's not clear if the cholesterol-lowering drugs protect against the disease

Key Blood Test Protein May Not Cause Heart Disease
CRP may only reflect existing cardiovascular trouble, study finds

Statins Lower Risk of Clots in Cancer Patients
Study found those who took them were less likely to get venous thromboembolism

Women Smokers Prone to Dangerous Blood Vessel Condition
Risk of abdominal aortic aneurysm is 8 times higher than in nonsmokers, study says

Next >
TOP CARS
  • Chevrolet Impala 2007, 3.5L, 6 CYL., Automatic, FI, Dark Silver Metallic. Call (252)335-0724...(more)
  • * Monthly payment rate based on 6,9% annual percentage rate for 72 months, with approved credit, cash or trade down payment, $...(more)
  • * Monthly payment rate based on 6,9% annual percentage rate for 72 months, with approved credit, cash or trade down payment, $...(more)
- View All Top Cars -
- Place An Ad -

The Daily Advance | Weather | Sports | Albemarle Life | Business | Opinion | Classifieds | Site Map
Cars | Jobs | Homes

Copyright Mon Dec 01 23:54:39 EST 2008 The Daily Advance All rights reserved. - The Daily Advance - Our Partners

By using this service, you accept the terms of our visitor agreement and privacy policy
Registered site users, you may edit your profile.
Having trouble? Visit our help & FAQ